Cargando…

Birth-weight, insulin levels, and HOMA-IR in newborns at term

BACKGROUND: Recent studies have demonstrated that low and high birth-weight at birth are risk factors of developing diabetes. The aim of this study was to determine if the abnormal birth-weight is related with hyperinsulinemia and elevated index of the Homeostasis Model assessment for Insulin Resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Simental-Mendía, Luis E, Castañeda-Chacón, Argelia, Rodríguez-Morán, Martha, Guerrero-Romero, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407515/
https://www.ncbi.nlm.nih.gov/pubmed/22770114
http://dx.doi.org/10.1186/1471-2431-12-94
_version_ 1782239345290248192
author Simental-Mendía, Luis E
Castañeda-Chacón, Argelia
Rodríguez-Morán, Martha
Guerrero-Romero, Fernando
author_facet Simental-Mendía, Luis E
Castañeda-Chacón, Argelia
Rodríguez-Morán, Martha
Guerrero-Romero, Fernando
author_sort Simental-Mendía, Luis E
collection PubMed
description BACKGROUND: Recent studies have demonstrated that low and high birth-weight at birth are risk factors of developing diabetes. The aim of this study was to determine if the abnormal birth-weight is related with hyperinsulinemia and elevated index of the Homeostasis Model assessment for Insulin Resistance (HOMA-IR) at birth, in at term newborns. METHODS: Newborns with gestational age between 38 and 41 weeks, products of normal pregnancies of healthy mothers aged 18 to 39 years, were eligible to participate. Small-for-gestational age (SGA) and large-for-gestational age (LGA) newborns were compared with appropriate-for-gestational (AGA) age newborns. Incomplete or unclear data about mother’s health status, diabetes, gestational diabetes, history of gestational diabetes, hypertension, pre-eclampsia, eclampsia, and other conditions that affect glucose metabolism were exclusion criteria. Hyperinsulinemia was defined by serum insulin levels ≥13.0 μU/mL and IR by HOMA-IR ≥2.60. Multiple logistic regression analysis was used to determine the odds ratio (OR) that computes the association between birth-weight (independent variable) with hyperinsulinemia and HOMA-IR index (dependent variables). RESULTS: A total of 107 newborns were enrolled; 13, 22, and 72 with SGA, LGA, and AGA, respectively. Hyperinsulinemia was identified in 2 (15.4%), 6 (27.3%), and 5 (6.9%) with SGA, LGA, and AGA (p=0.03), whereas IR in 3 (23.1%), 8 (36.4%), and 10 (13.9%) newborns with SGA, LGA and AGA (p=0.06). The LGA showed a strong association with hyperinsulinemia (OR 5.02; CI 95%, 1.15-22.3; p=0.01) and HOMA-IR (OR 3.54; CI 95%, 1.03-12.16; p=0.02); although without statistical significance, the SGA showed a tendency of association with hyperinsulinemia (OR 2.43; CI 95%, 0.43-17.3 p=0.29) and HOMA-IR (OR 1.86; CI 95%, 0.33-9.37; p=0.41). CONCLUSIONS: Our results suggest that LGA is associated with hyperinsulinemia and elevated HOMA-IR at birth whereas the SGA show a tendency of association.
format Online
Article
Text
id pubmed-3407515
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34075152012-07-29 Birth-weight, insulin levels, and HOMA-IR in newborns at term Simental-Mendía, Luis E Castañeda-Chacón, Argelia Rodríguez-Morán, Martha Guerrero-Romero, Fernando BMC Pediatr Research Article BACKGROUND: Recent studies have demonstrated that low and high birth-weight at birth are risk factors of developing diabetes. The aim of this study was to determine if the abnormal birth-weight is related with hyperinsulinemia and elevated index of the Homeostasis Model assessment for Insulin Resistance (HOMA-IR) at birth, in at term newborns. METHODS: Newborns with gestational age between 38 and 41 weeks, products of normal pregnancies of healthy mothers aged 18 to 39 years, were eligible to participate. Small-for-gestational age (SGA) and large-for-gestational age (LGA) newborns were compared with appropriate-for-gestational (AGA) age newborns. Incomplete or unclear data about mother’s health status, diabetes, gestational diabetes, history of gestational diabetes, hypertension, pre-eclampsia, eclampsia, and other conditions that affect glucose metabolism were exclusion criteria. Hyperinsulinemia was defined by serum insulin levels ≥13.0 μU/mL and IR by HOMA-IR ≥2.60. Multiple logistic regression analysis was used to determine the odds ratio (OR) that computes the association between birth-weight (independent variable) with hyperinsulinemia and HOMA-IR index (dependent variables). RESULTS: A total of 107 newborns were enrolled; 13, 22, and 72 with SGA, LGA, and AGA, respectively. Hyperinsulinemia was identified in 2 (15.4%), 6 (27.3%), and 5 (6.9%) with SGA, LGA, and AGA (p=0.03), whereas IR in 3 (23.1%), 8 (36.4%), and 10 (13.9%) newborns with SGA, LGA and AGA (p=0.06). The LGA showed a strong association with hyperinsulinemia (OR 5.02; CI 95%, 1.15-22.3; p=0.01) and HOMA-IR (OR 3.54; CI 95%, 1.03-12.16; p=0.02); although without statistical significance, the SGA showed a tendency of association with hyperinsulinemia (OR 2.43; CI 95%, 0.43-17.3 p=0.29) and HOMA-IR (OR 1.86; CI 95%, 0.33-9.37; p=0.41). CONCLUSIONS: Our results suggest that LGA is associated with hyperinsulinemia and elevated HOMA-IR at birth whereas the SGA show a tendency of association. BioMed Central 2012-07-07 /pmc/articles/PMC3407515/ /pubmed/22770114 http://dx.doi.org/10.1186/1471-2431-12-94 Text en Copyright ©2012 Simental-Mendía et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Simental-Mendía, Luis E
Castañeda-Chacón, Argelia
Rodríguez-Morán, Martha
Guerrero-Romero, Fernando
Birth-weight, insulin levels, and HOMA-IR in newborns at term
title Birth-weight, insulin levels, and HOMA-IR in newborns at term
title_full Birth-weight, insulin levels, and HOMA-IR in newborns at term
title_fullStr Birth-weight, insulin levels, and HOMA-IR in newborns at term
title_full_unstemmed Birth-weight, insulin levels, and HOMA-IR in newborns at term
title_short Birth-weight, insulin levels, and HOMA-IR in newborns at term
title_sort birth-weight, insulin levels, and homa-ir in newborns at term
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407515/
https://www.ncbi.nlm.nih.gov/pubmed/22770114
http://dx.doi.org/10.1186/1471-2431-12-94
work_keys_str_mv AT simentalmendialuise birthweightinsulinlevelsandhomairinnewbornsatterm
AT castanedachaconargelia birthweightinsulinlevelsandhomairinnewbornsatterm
AT rodriguezmoranmartha birthweightinsulinlevelsandhomairinnewbornsatterm
AT guerreroromerofernando birthweightinsulinlevelsandhomairinnewbornsatterm